Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00147654Phase 4Completed
A Phase 4 trial of tolterodine in overactive bladder (OAB), bladder outlet obstruction (BOO), sponsored by Viatris. Started Nov 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00147654.